Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer

Published:2023-06-17 Issue:8 Volume:41 Page:2173-2178
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Vanneste Matthias^ORCID,van der Heij Bart,Christiaansen Charlotte Elisabeth,Berendsen Chris L.,Driessen Elisabeth Johanna Margaretha,Bruins Harman Maxim

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-023-04469-x.pdf

Reference16 articles.

1. IARC, Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021 [access date March 2022]. Accessible through: https://gco.iarc.fr/today/online-analysis-table

2. Compérat E, Larre S, Roupret M et al (2015) Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch 466:589–594. https://doi.org/10.1007/s00428-015-1739-2

3. Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73(6):925–933. https://doi.org/10.1016/j.eururo.2018.02.014

4. Naselli A, Hurle R, Paparella S (2018) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4(4):558–567. https://doi.org/10.1016/j.euf.2016.12.011

5. Babjuk M, Burger M, Compérat E et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and Carcinoma in Situ). Eur Urol 81(1):75–94. https://doi.org/10.1016/j.eururo.2021.08.010